Therapeutics Related News

Cell Design Labs’ Scientific Founder Co-Authors Review Article Illustrating Power and Potential of Engineered Human Cells to Treat Cancer

EMERYVILLE, Calif., Feb. 09, 2017 (GLOBE NEWSWIRE) -- Cell Design Labs, Inc. today announced that its scientific founder, Wendell Lim, Ph.D., co-authored a comprehensive review article on engineered cell therapies entitled, “The Principles of Engineering Immune Cells to Treat Cancer” [...]

By | February 14th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Meet the Speakers: Will Synthetic Biology be the Key to Our Future Health?

SynBioBeta’s fifth annual London conference is fast approaching, with leaders in industry, academia, and investment once again set to converge on Imperial College London between April 4th and 6th. A full schedule of exciting events and sessions has been lined [...]

By | February 1st, 2017|BioPharma & Healthcare, News, Pharmaceuticals, Therapeutics|

Exemplar Genetics Awarded Subcontract to Advance New Therapeutic Models for Sickle Cell Disease

SIOUX CENTER, Iowa, Jan. 26, 2017 /PRNewswire/ -- Exemplar Genetics, a wholly owned subsidiary of Intrexon Corporation (NYSE: XON) committed to enabling the study of life-threatening human diseases, has been awarded a subcontract to create genetically engineered miniswine models of sickle [...]

By | January 30th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Intrexon to Acquire GenVec to Expand Industry-Leading Gene Delivery Platform

GERMANTOWN, Md., and GAITHERSBURG, Md., Jan. 24, 2017 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced that it has entered into [...]

By | January 24th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

RoosterBio Inc. Unites with Manufacturing Innovation Institutes, Joining Manufacturing USA Network

FREDERICK, MARYLAND (PRWEB) JANUARY 18, 2017 - Announced in December 2016, RoosterBio is now part of two new federally funded bio-focused Manufacturing Innovation Institutes (MII). U.S. Secretary of Commerce Penny Pritzker has announced the award of a new National Institute [...]

By | January 20th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Horizon broadens industry-leading gene editing capabilities through extension of key CRISPR license and grant-funded research

Cambridge, UK, 16 January 2017: Horizon Discovery Group plc (LSE: HZD) ("Horizon" or the “Company”), the world leader in the application of gene editing technologies, today announces that it has broadened its gene editing capabilities through the amendment of a [...]

By | January 17th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|